Table 2.
Region | N | S | dN | dS | k | π Jukes Cantor | H | Hd | H† | Tajima's D | Fu and Li's D* | Fu and Li's F* |
All | 56 | 13 (13) | 10 | 3 | 4.041 | 0.0032 | 8 | 0.771 | — | 1.259 | 1.513** | 1.688** |
Asia | 7 | 12 (12) | 9 | 3 | 6 | 0.00475 | 4 | 0.857 | 2 | 1.225 | 1.573‡ | 1.642** |
Egypt/Libya | 7 | 3 (3) | 0 | 3 | 1.714 | 0.00135 | 2 | 0.571 | 0 | 1.811 | 1.297 | 1.522 |
Europe/United States | 6 | 4 (4) | 1 | 3 | 2.4 | 0.00189 | 3 | 0.8 | 0 | 1.640 | 1.641 | 1.670 |
Nigeria | 31 | 11 (3) | 8 | 3 | 4.275 | 0.00338 | 4 | 0.546 | 2 | 1.766 | 1.440** | 1.805** |
Venezuela | 5 | 2 (2) | 0 | 2 | 1.2 | 0.00095 | 2 | 0.6 | 0 | 1.459 | 1.459 | 1.432 |
All analyses were restricted to the signal peptide cleaved EtAMA1 ectodomain. Tajima’s D and Fu and Li’s D* and F* tests were used to assess of the extent or neutrality of signatures of selection with significance: **P < 0.05; ‡P < 0.02. All measures were calculated using DnaSP v5.10.01. dN, the number of nonsynonymous variant sites; dS, the number of synonymous variant sites; H, the number of sequence haplotypes detected; H†, the number of haplotypes specific to a region; Hd, the haplotype diversity; k, the average number of pairwise differences; N, the number of sequences tested; π, nucleotide diversity, calculated with the Jukes Cantor correction; S, the number of variant sites detected, with the number of parsimony-informative variant sites shown in parentheses.